Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Intraosseous adipose mesenchymal stem cells and plasma rich in growth factors: A promising approach for articular cartilage and subchondral bone regeneration.

Torres-Torrillas M., Damiá E., Peláez P., Del Romero A., Miguel-Pastor L., Rubio M.

Animal Study on Osteoarthritis, Cartilage Damage, published in Res Vet Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Res Vet Sci (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40967102
DOI
10.1016/j.rvsc.2025.105896

Abstract (original English)

Intra-articular (IA) infiltration of plasma rich in growth factors (PRGF) and adipose-derived mesenchymal stem cells (ASCs) have been proposed as a potential treatment for patients with osteoarthritis, due to their regenerative properties and ability to promote cartilage healing. However, in patients with severe osteoarthritis, where not only cartilage but also the subchondral bone is affected, IA infiltration of these regenerative therapies appears to be less effective. To overcome this limitation, intraosseous (IO) infiltration of PRGF and ASCs has recently been proposed. The objective of this study was to evaluate the effectiveness of IO infiltration with PRGF, ASCs, and their combination (PRGF+ASCs) in treating acute full-thickness chondral lesions in a rabbit model. Forty healthy rabbits were allocated into four groups based on the IO treatment administered (control, PRGF, ASCs, or PRGF+ASCs). A full-thickness chondral defect was created in the medial femoral condyle, followed by IO treatment infiltration. Additionally, all rabbits, regardless of group, received an IA infiltration of PRGF. At 56- and 84-days post-infiltration, the groups treated with any of the three regenerative therapies showed improved histological outcomes compared to the control group, with the PRGF+ASCs group demonstrating the most significant cartilage healing. The results suggest that IO infiltrati

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsRabbitsCartilage, ArticularBone RegenerationMesenchymal Stem Cell TransplantationIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsAdipose TissueMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research